JCI — Johnson Controls International plc

Sell-side tone is firmly positive: 28 Buy vs. 17 Hold and zero Sell ratings, with Morgan Stanley and Bernstein lifting targets to $180–190 after the Q3 FY26 beat, and the FMP consensus target at $170.57 (range $144–$190; recent-3 average $181.67). Institutional ownership holds near 90%. Price action broadly confirms it — as of 2026-09-13 the stock was up 12.18% over six months and 0.74% over the past week — but the -4.44% one-month return shows profit-taking near the $157.06 52-week high, and early-August insider sales (~$3.6M at a weighted average $153.07, well below the last close) are a mild caution flag rather than a thesis-breaker.

Revenue growth is clearly ACCELERATING, not merely stable. YoY growth by fiscal quarter: Q1 FY25 +4.2%, Q2 FY25 +1.4%, Q3 FY25 +2.6%, Q4 FY25 +3.1%, then Q1 FY26 +6.8%, Q2 FY26 +8.2%, Q3 FY26 +9.3% ($6,614M vs. $6,052M). That is a genuine inflection off a soft FY25 base and matches the commercial-HVAC / data-center cooling demand described in the research brief. Margins tell the same story: operating margin went 9.7% (Q1 FY25) → 14.7% (Q1 FY26); 11.3% → 13.1% (Q2); 13.7% → 14.9% (Q3, $987M on $6,614M). TTM gross margin is 36.7% and net margin 14.3%. Diluted EPS rose $0.63 → $0.85 (Q1), $0.72 → $1.00 (Q2), $1.07 → $1.22 (Q3), with company-reported adjusted EPS of $1.42 in Q3 FY26. Two caveats on the GAAP slope: Q4 FY25 net income of $1,693M was roughly double operating income of $830M on a ~$860M non-operating (divestiture) gain, and Q2 FY24 printed a -$277M net loss on a -$142M operating loss from charges — so the TTM GAAP EPS of $5.897 is flattered by a one-off and the multi-year GAAP line is choppier than the underlying business. Free cash flow confirms the improvement: Q3 FY26 FCF was $1,501M (on $1,596M OCF) versus $901M a year earlier; TTM FCF through 2026-06-30 is $1,997M, held down by a -$572M FY25 Q4 that reflected divestiture/restructuring cash costs, not operational weakness. Conclusion: structural improvement, not a one-quarter blip.

Fair-to-expensive as of 2026-09-13. The trailing P/E of 25.3x on TTM EPS of $5.897 is misleading because that TTM includes the ~$860M Q4 FY25 divestiture gain — the honest number is the forward multiple: $146.01 ÷ $5.072 next-FY consensus EPS = 28.8x, ABOVE the trailing P/E and roughly in line with (slightly above) the 5-year average trailing P/E of 28.73x. P/S of 3.54x is a ~69% premium to the 5-year average of 2.10x. The PEG of 0.358 looks cheap but is an artifact — the trailing growth denominator is inflated by the FY24 Q2 loss, so ignore it. P/B of 6.57x against an ROIC of only 8.7% is the weakest link: JCI earns little more than its cost of capital on invested capital, despite a headline ROE of 25.5% that is flattered by leverage. The screener's EV/EBITDA of 27.3x equates to roughly 22x on a normalized ~$4.2B EBITDA. Data caveat: the vendor classifies JCI as 'Basic Materials / Construction Materials,' which is wrong — it is an Industrials/building-technologies company — though the ratio screen benchmarks against the full S&P 500, so the distortion is limited. Net: a full-to-premium multiple that only holds if the beats keep coming.

The market is already paying for the good news. At $146.01 on 2026-09-13, an investor is paying 28.8x FY27 consensus EPS of $5.072 — or roughly 30–32x FY26 adjusted EPS (~$4.60–4.85) — versus 5- and 6-month price gains of just 0.72% and 12.18%. To justify $146 at a more normalized 25x, you'd need about $5.84 of EPS, roughly 15% above the current FY27 consensus, meaning either estimates must keep climbing or the premium multiple must persist. What's embedded: the ~$1B CDU pipeline converting, sustained operating-margin expansion, and continued high-single-digit organic growth. What's NOT embedded: a backlog-conversion slowdown, a softer hyperscaler capex cadence, or a conservative FY27 guide at the fiscal Q4 print. The asymmetry into that print is unfavourable — a beat that merely confirms the trend probably holds the multiple, while a guidance shortfall compresses it quickly from a full starting point. Practical read: trim into strength toward $155–160; the risk/reward improves in the $140–145 zone where the 20-/50-day averages sat.

Range-bound-to-uptrending as of 2026-09-13. RSI(14) stood at 53.04 — dead neutral, neither overbought nor oversold. The $146.01 price sat above all three key averages: +1.28% vs. the SMA20 (≈$144.16), +0.85% vs. the SMA50 (≈$144.78), and +7.88% vs. the SMA200 (≈$135.35). The wide spread to the 200-day confirms a primary uptrend, while the tight 20/50-day cluster at roughly $144–145 shows consolidation. Return profile: +0.74% 1-week, -4.44% 1-month, +0.72% 3-month, +12.18% 6-month — a one-month pullback inside a rising six-month trend, not a breakdown. Entry implication: with RSI at 53 there is no momentum edge to buy or sell; the $144–145 cluster is the line to watch — a decisive close below it with RSI under ~45 would signal a medium-term trend break toward the 200-day, while a reclaim of $157 re-opens the highs.

• AI / data-center cooling supercycle: hyperscale spend on liquid cooling and coolant distribution units (CDUs) is the single biggest structural tailwind — JCI's ~$1B CDU pipeline and multi-year data-center agreements are the core of the growth story and the reason the multiple is where it is.
• Interest rates and non-residential construction financing: high rates still pressure traditional commercial real-estate capex, partially offset by mission-critical and energy-transition spending; rate cuts would be a direct tailwind to the order book and to the traditional commercial HVAC cycle.
• Energy-efficiency and decarbonization mandates (refrigerant transitions, building-performance rules, electrification) structurally pull forward HVAC/controls replacement demand independent of the new-build cycle.
• Supply-chain and electrical-grid component lags of 3–4 months — management frames these as timing bottlenecks rather than lost demand, but they can shift revenue between quarters and complicate the Q4 print.
• Theme correlation risk: JCI is now partly valued as an AI-infrastructure name, so a de-rating of AI-adjacent industrials or sector rotation away from them hits the multiple regardless of JCI's own execution. Tariffs and FX add noise given the international revenue base.

• Fiscal Q4 2026 results and initial FY27 guidance — backlog conversion rate and order velocity are the numbers that matter; this is the next hard catalyst and lands against a full multiple.
• Conversion of the ~$1B CDU pipeline and multi-year data-center agreements into recognized revenue, which would validate the premium multiple.
• Continued operating-margin expansion and further portfolio simplification post the Residential & Light Commercial HVAC divestiture to Bosch (potential bolt-ons or accelerated buybacks).
• Further sell-side estimate and target revisions — Morgan Stanley and Bernstein are already at $180–190; upward estimate revisions would help hold the ~29x forward multiple.
• Fed rate cuts easing non-residential construction financing costs, which would revive the more cyclical traditional commercial HVAC and controls demand.

• Valuation risk is the biggest one: 28.8x next-FY EPS and 3.54x sales vs. a 2.10x five-year average P/S means multiple compression alone can produce a large drawdown without the business actually breaking.
• Weak returns on capital — ROIC of 8.7% (ROE of 25.5% is leverage-flattered) means JCI earns little above its cost of capital, which structurally caps how much multiple the equity deserves and undermines the quality case.
• Data-center capex cyclicality and competition: if hyperscaler spending decelerates, or Vertiv/Trane/Schneider take share of liquid-cooling and CDU projects, the growth narrative and the premium multiple deflate together.
• Earnings-quality noise cuts both ways — Q4 FY25 net income was double operating income on a one-off divestiture gain, and Q4 FY25 FCF was -$572M from restructuring/divestiture cash costs, so headline GAAP figures can mislead in either direction.
• Balance-sheet liquidity: current ratio of 0.97 is below 1.0 with $8.3B of long-term debt, and cash flow is strong but lumpy across quarters.
• Insider selling in early August 2026 (~$3.6M at a weighted average $153.07) plus any sustained weakness in non-residential construction or a delay in the 3–4 month component backlog.

JCI is a genuinely improving business trading at a full price — so own it on weakness, don't chase it here. The operating story is real: revenue growth accelerated to +9.3% YoY in Q3 FY26, operating margin expanded to 14.9% from 13.7% a year earlier, quarterly FCF hit $1,501M, and the data-center cooling pipeline gives multi-year visibility well beyond the trailing numbers. The problem is what you pay for it: 28.8x next-FY consensus EPS and 3.54x sales against a 2.10x five-year average P/S, with an ROIC of only 8.7% to justify the premium. That combination makes $146 a poor entry point with the fiscal Q4 print and FY27 guide immediately ahead, and the $140–145 moving-average cluster a materially better one. Not a broken thesis — a fair-to-full valuation with unfavourable near-term asymmetry.

Two blended methods as of 2026-09-13. (1) 29x forward P/E — a modest premium to JCI's own 5-year average trailing multiple of 28.7x, justified by accelerating revenue (+9.3% YoY in Q3 FY26) and 120–500bps of YoY operating-margin expansion — applied to the $5.072 next-FY consensus EPS gives $147. (2) A 3.75% target normalized free-cash-flow yield on ~$3.5B of run-rate FCF (the nine-month FY26 figure of $2.57B annualized, excluding the restructuring-distorted -$572M FY25 Q4) across ~610M shares = $5.74/share ÷ 0.0375 = $153. Averaging the two gives ~$150, which I nudge to $152 to reflect the multi-year data-center CDU pipeline that neither method explicitly captures — roughly 4% above the $146.01 price and well below the $170+ sell-side consensus, which embeds a more optimistic FY27 EPS path.